Lagura, Janet .

HRN: 27-14-51  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2025
CEFUROXIME 1.5GM (VIAL)
05/24/2025
05/24/2025
IV
1.5g
PTOR
CPD
Remove - Pending Acceptance
05/25/2025
CEFUROXIME 500MG (TAB)
05/25/2025
06/01/2025
PO
BID
500mg
SP CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: